"Looking for a dialysis center? Fresenius Kidney Care Opelousas in Opelousas, LA at 528 E Vine St offers hemodialysis and peritoneal dialysis services to people with chronic kidney disease. Get reviews, services, hours, directions and more."

During the past decade, FMC Opelousas conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "FMC Opelousas" #1 collaborator was "Hospira, now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "FMC Opelousas" are "Chronic Kidney Disease" (1 trials), "Chronic Renal Failure" (1 trials) and "Chronic Renal Failure Requiring Hemodialysis" (1 trials). Many other conditions were trialed in "FMC Opelousas" in a lesser frequency.

Most popular intervention types in "FMC Opelousas" are "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Epoetin Hospira" (2 trials) and "Epogen Amgen" (1 trials). Other intervention names were less common.

The vast majority of trials in "FMC Opelousas" are 2 trials for "All" genders.

Currently, there are NaN active trials in "FMC Opelousas". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in FMC Opelousas, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in FMC Opelousas, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".